157 related articles for article (PubMed ID: 25250867)
1. Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients.
Sherston SN; Vogt K; Schlickeiser S; Sawitzki B; Harden PN; Wood KJ
Am J Transplant; 2014 Nov; 14(11):2617-22. PubMed ID: 25250867
[TBL] [Abstract][Full Text] [Related]
2. Helios expression and Foxp3 TSDR methylation of IFNy+ and IFNy- Treg from kidney transplant recipients with good long-term graft function.
Trojan K; Unterrainer C; Weimer R; Bulut N; Morath C; Aly M; Zhu L; Opelz G; Daniel V
PLoS One; 2017; 12(3):e0173773. PubMed ID: 28296931
[TBL] [Abstract][Full Text] [Related]
3. Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer.
Peters FS; Peeters AMA; Mandaviya PR; van Meurs JBJ; Hofland LJ; van de Wetering J; Betjes MGH; Baan CC; Boer K
Clin Epigenetics; 2018; 10():81. PubMed ID: 29946375
[TBL] [Abstract][Full Text] [Related]
4. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
[TBL] [Abstract][Full Text] [Related]
5. Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance.
Braza F; Dugast E; Panov I; Paul C; Vogt K; Pallier A; Chesneau M; Baron D; Guerif P; Lei H; Laplaud DA; Volk HD; Degauque N; Giral M; Soulillou JP; Sawitzki B; Brouard S
J Am Soc Nephrol; 2015 Aug; 26(8):1795-805. PubMed ID: 25556168
[TBL] [Abstract][Full Text] [Related]
6. Elevated Methylation of FOXP3 (Forkhead Box P3)-TSDR (Regulatory T-Cell-Specific Demethylated Region) Is Associated With Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndrome.
Zhu L; Jia L; Liu Z; Zhang Y; Wang J; Yuan Z; Hui R
Hypertension; 2019 Sep; 74(3):581-589. PubMed ID: 31327269
[TBL] [Abstract][Full Text] [Related]
7. Immune phenotype predicts risk for posttransplantation squamous cell carcinoma.
Carroll RP; Segundo DS; Hollowood K; Marafioti T; Clark TG; Harden PN; Wood KJ
J Am Soc Nephrol; 2010 Apr; 21(4):713-22. PubMed ID: 20110382
[TBL] [Abstract][Full Text] [Related]
8. Metastasis of skin squamous cell carcinoma in kidney transplant recipients.
Alves FFC; de Jesus LCB; Cristelli MP; Enokihara MMSES; Hirata SH; Facina ADS; Tomimori J
Int J Dermatol; 2024 May; 63(5):560-564. PubMed ID: 38263692
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A
Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759
[TBL] [Abstract][Full Text] [Related]
10. Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer.
Peters FS; Peeters AMA; van den Bosch TPP; Mooyaart AL; van de Wetering J; Betjes MGH; Baan CC; Boer K
Clin Exp Immunol; 2019 Sep; 197(3):341-351. PubMed ID: 31059128
[TBL] [Abstract][Full Text] [Related]
11. Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
Carroll RP; Hester J; Wood KJ; Harden PN
Nephrol Dial Transplant; 2013 Feb; 28(2):462-5. PubMed ID: 23223314
[TBL] [Abstract][Full Text] [Related]
12. Non-melanoma skin cancer in Portuguese kidney transplant recipients - incidence and risk factors.
Pinho A; Gouveia M; Cardoso JC; Xavier MM; Vieira R; Alves R
An Bras Dermatol; 2016; 91(4):455-62. PubMed ID: 27579740
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
[TBL] [Abstract][Full Text] [Related]
14. The immune phenotype may relate to cancer development in kidney transplant recipients.
Hope CM; Grace BS; Pilkington KR; Coates PT; Bergmann IP; Carroll RP
Kidney Int; 2014 Jul; 86(1):175-83. PubMed ID: 24429406
[TBL] [Abstract][Full Text] [Related]
15. IFNγ+ Treg in-vivo and in-vitro represent both activated nTreg and peripherally induced aTreg and remain phenotypically stable in-vitro after removal of the stimulus.
Daniel V; Trojan K; Adamek M; Opelz G
BMC Immunol; 2015 Aug; 16():45. PubMed ID: 26268522
[TBL] [Abstract][Full Text] [Related]
16. Risk prediction model for cutaneous squamous cell carcinoma in adult cardiac allograft recipients.
Nair N; Hu Z; Du D; Gongora E
World J Transplant; 2021 Mar; 11(3):54-69. PubMed ID: 33816146
[TBL] [Abstract][Full Text] [Related]
17. Mbd2 promotes foxp3 demethylation and T-regulatory-cell function.
Wang L; Liu Y; Han R; Beier UH; Thomas RM; Wells AD; Hancock WW
Mol Cell Biol; 2013 Oct; 33(20):4106-15. PubMed ID: 23979593
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs.
Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V
Front Immunol; 2021; 12():716559. PubMed ID: 34335631
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Genetic Factors Associated with Cutaneous Squamous Cell Carcinoma in Kidney and Heart Transplant Recipients.
Sanders ML; Karnes JH; Denny JC; Roden DM; Ikizler TA; Birdwell KA
Transplant Direct; 2015 May; 1(4):. PubMed ID: 26146661
[TBL] [Abstract][Full Text] [Related]
20. Parotid metastases of cutaneous squamous cell carcinoma in renal transplant recipients: Case series and literature review.
Mokos M; Bašić-Jukić N
Dermatol Ther; 2021 May; 34(3):e14907. PubMed ID: 33619803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
